About this site & how it works

MedCheck is published by River De, registered in China. Editorial responsibility sits with River De, Founder & Editor. I built MedCheck after seeing how confusing GLP-1 eligibility rules are across states and insurers, and wanted a fast, transparent tool that gives people a clear starting point rather than a medical verdict.

Every factual claim on this site traces to a public source. The main ones:

The calculation is deliberately simple and fully disclosed — there is no proprietary score.

BMI. Weight in kilograms divided by height in metres squared. Imperial entries are converted first. The result is rounded to one decimal place.

Tiers. A BMI of 30 or above is reported as meeting the threshold telehealth programs commonly screen at. Between 27 and 30, the snapshot says you may meet criteria if a weight-related health condition applies, because that is the second threshold those programs publish. Below 27, the snapshot says standard screening criteria likely do not apply and shows no partner referral.

These thresholds mirror the eligibility criteria published by telehealth weight-management providers, which in turn follow the FDA-approved labeling for anti-obesity medications. They are screening conventions, not clinical decisions — see the disclaimer for what BMI does not capture.

• Everything is dated. State pages show when the facts on them were last verified. FDA status shows the FDA's own update date, not ours.
• Nothing ships unverified. A state page is only indexed once its coverage and telehealth claims have been checked against primary sources. Pages awaiting verification are kept out of search results rather than published with a guess.
• Re-verification is scheduled. Medicaid coverage changed in several states during 2025–2026, in both directions. Each state page carries a review deadline and is re-checked on that cadence.
• No stale urgency. Shortage language on every page is generated from the current FDA status. When a shortage is resolved, pages say so. We do not keep scarcity messaging alive to drive clicks.
• Corrections are welcome. Write to contact@myqualifycheck.com. We fix errors and note the date of the correction on the page.

Affiliate commissions. When the snapshot indicates your answers line up with published screening criteria, we show a link to a telehealth provider, clearly labeled as sponsored. If you sign up, we may earn a commission at no additional cost to you.

Two constraints we hold ourselves to, because an incentive you can't see is the thing that makes sites like this untrustworthy:

• Commission rates never influence the thresholds, the shortage status, or the state information. Those come from the sources in §2.
• If your answers fall below the screening thresholds, we show no referral at all — even though that means no revenue from that visit.

Full detail is in the affiliate disclosure.

• We don't store your answers. The privacy policy explains exactly what happens to them.
• We don't attach health information to outbound tracking links.
• We don't claim state-level shortage data, because the FDA doesn't publish any.
• We don't contact people who post about medication access problems in online communities to pitch them links.
• We don't publish “medically reviewed” bylines for reviews that didn't happen.

Corrections, press, partnership, or privacy requests: contact@myqualifycheck.com. We are not able to answer personal medical questions — please bring those to a licensed clinician.